research JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis 223 citations , September 2018 in “Rheumatology” JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.
research Successful Treatment of Extensive Ritlecitinib-Refractory Alopecia Areata with Upadacitinib June 2026 in “Clinical Cosmetic and Investigational Dermatology” Upadacitinib effectively treated alopecia areata when other treatments failed.
research Successful Treatment of Extensive Ritlecitinib-Refractory Alopecia Areata with Upadacitinib June 2026 in “DOAJ (DOAJ: Directory of Open Access Journals)” Upadacitinib effectively treated alopecia areata when other treatments failed.
research A novel therapeutic paradigm for patients with extensive alopecia areata 30 citations , May 2016 in “Expert Opinion on Biological Therapy” New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.
research Advances in the mechanism and new therapies of alopecia areata October 2023 in “International journal of rheumatic diseases” New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.